Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
Voir aussi
Recommandation vaccinale
20/09/2022
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
jjw257DNpXepr4gZ
